NUP155 and glioma: In particular, NUP155 expression was positively correlated with DNAss in BRCA, CESC, CHOL, glioma (GBMLGG), HNSC, KIRC, KIRP, pan-kidney cohort (KICH + KIRC + KIRP) (KIPAN), LGG, LUAD, LUSC, MESO, PAAD, stomach and esophageal carcinoma (STES), SARC, SKCM, STAD, and TGCT and negatively correlated with DNAss in BLCA.